The purpose of screening is early diagnosis and treatment. Screening tests are usually done for people without any current symptoms, but who may be at high risk for certain diseases or conditions.
There are several tests that doctors may use to screen for Alzheimer disease. Examples include:
Genetic testing is available, but it is not routinely used in most people. It may be done in those with a family history of early-onset Alzheimer. Researchers are also studying whether specialized imaging tests would be helpful in screening for Alzheimer disease. Cerebrospinal fluid (CSF) evaluation via a lumbar puncture may play a role in the diagnosis of Alzheimer disease.
10 early signs and symptoms of Alzheimer's. Alzheimer’s Association website. Available at: http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp. Accessed October 2, 2017.
Alzheimer dementia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia. Updated August 21, 2017. Accessed October 2, 2017.
Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at: https://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-medications-fact-sheet. Updated May 18, 2017. Accessed October 2, 2017.
Drago V, Babiloni C, Bartres-Faz D, et al. Disease tracking markers for Alzheimer’s disease at the prodromal (MCI) stage. J Alzhemier’s Dis. 2011;26 Suppl 3:159-199.
Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560-574.
Roalf DR, Moberg PJ, Xie SX, et al. Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2012;9(5):529-537.
Wolk DA, Klunk W. Update on amyloid imaging: from healthy aging to Alzheimer's disease. Curr Neurol Neurosci Rep. 2009;9(5):345-352.
7/6/2009 DynaMed Plus Systematic Literature Surveillance https://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia: Brown J, Pengas G, et al. Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ. 2009;338:b2030.
Last reviewed September 2017 by EBSCO Medical Review Board Rimas Lukas, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×